迈瑞医疗收盘下跌1.72%，滚动市盈率24.74倍，总市值2755.03亿元

Group 1 - The core viewpoint of the articles highlights that Mindray Medical's stock closed at 227.23 yuan, down 1.72%, with a rolling PE ratio of 24.74 times and a total market capitalization of 275.503 billion yuan [1] - In comparison to the industry, Mindray Medical's PE ratio is significantly lower than the average of 53.65 times and the median of 37.22 times, ranking 51st in the industry [1] - The company experienced a net outflow of main funds amounting to 67.8086 million yuan on August 1, with a total outflow of 172.3829 million yuan over the past five days [1] Group 2 - Mindray Medical's main business includes the research, manufacturing, marketing, and service of medical devices, with key products in life information and support, in vitro diagnostics, medical imaging, electrophysiology, and vascular intervention [1] - The latest quarterly report for Q1 2025 shows that the company achieved operating revenue of 8.237 billion yuan, a year-on-year decrease of 12.12%, and a net profit of 2.629 billion yuan, down 16.81%, with a gross profit margin of 62.53% [1] - The PE ratios of other companies in the medical device industry vary, with the average at 53.65 times and the median at 37.22 times, indicating a competitive landscape [2]